SEC Form 4
Niki BioSolutions, Inc. (NIKI) insider trading
No open-market NIKI insider purchases or sales were filed in the 12 months to Oct 26, 2026.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $0
- 0 filings
Who traded NIKI, and when
NIKI daily close from Jul 20, 2026 to Oct 26, 2026, between $1.83 and $10.17, last $1.90. No open-market insider purchases or sales were filed in this period.
No open-market insider purchases or sales were filed in the last 12 months.
Open-market trades
0 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| No open-market purchases or sales in the last 12 months. | ||||||
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
| No open-market purchases or sales in the last 12 months. | |||||||
GET /stocks/filings/vX/form-4?tickers=NIKI&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"NIKI"
],
"issuer_cik": "0001734005",
"owner_cik": "0001438091",
"accession_number": "0001213900-26-111383",
"form_type": "4",
"filing_date": "2026-10-21",
"period_of_report": "2026-07-22",
"issuer_name": "Niki BioSolutions, Inc.",
"issuer_trading_symbol": "NIKI",
"owner_name": "Sheinerman Kira",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "derivative",
"record_type": "transaction",
"security_title": "Stock Options",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-07-22",
"transaction_code": "A",
"equity_swap_involved": false,
"transaction_shares": 8000,
"transaction_price_per_share": 0,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 8000,
"transaction_value": 0,
"exercise_price": 8.83,
"expiration_date": "2036-07-22",
"underlying_security_title": "Common Stock",
"underlying_security_shares": 8000,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The options vest as follows: (i) 2,000 options vested immediately upon the closing of the merger; and (ii) the remaining 6,000 options vest in three equal quarterly installments of 2,000 options each, commencing on the first business day of the first full quarter following the effective date of the merger."
}
]
},
{
"tickers": [
"NIKI"
],
"issuer_cik": "0001734005",
"owner_cik": "0001438091",
"accession_number": "0001213900-26-111384",
"form_type": "4",
"filing_date": "2026-10-21",
"period_of_report": "2026-07-22",
"issuer_name": "Niki BioSolutions, Inc.",
"issuer_trading_symbol": "NIKI",
"owner_name": "Sheinerman Kira",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "derivative",
"record_type": "transaction",
"security_title": "Stock Options",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-07-22",
"transaction_code": "A",
"equity_swap_involved": false,
"transaction_shares": 8000,
"transaction_price_per_share": 0,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 8000,
"transaction_value": 0,
"exercise_price": 8.83,
"expiration_date": "2036-07-22",
"underlying_security_title": "Common Stock",
"underlying_security_shares": 8000,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The options vest as follows: (i) 2,000 options vested immediately upon the closing of the merger; and (ii) the remaining 6,000 options vest in three equal quarterly installments of 2,000 options each, commencing on the first business day of the first full quarter following the effective date of the merger."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
How current is NIKI’s insider data?
These are NIKI Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track NIKI insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for NIKI every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.